{"id":"W2342581896","doi":"10.1016/j.biologicals.2016.03.006","title":"Switching to biosimilar infliximab (CT-P13): Evidence of clinical safety, effectiveness and impact on public health","year":2016,"lang":"en","type":"review","venue":"Biologicals","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":84,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Infliximab; Medicine; Public health; Intensive care medicine; Internal medicine; Pathology; Disease","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002543383,0.0005333371,0.001471662,0.001808308,0.0002157605,0.001300861,0.0006047941,0.001498631,0.002816939],"category_scores_gemma":[0.004899372,0.000237311,0.0009823022,0.001763652,0.000507356,0.001041515,0.0005252916,0.001299262,0.0006599007],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007227513,"about_ca_system_score_gemma":0.002499681,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009938087,"about_ca_topic_score_gemma":0.001582528,"domain_scores_codex":[0.9987409,0.0003556682,0.0002649001,0.0001619708,0.000418631,0.00005798614],"domain_scores_gemma":[0.9960241,0.002772023,0.0005407982,0.0000586295,0.000536521,0.00006780261],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001708308,0.00005952878,0.0003868784,0.07523131,0.0004002922,0.0002017458,0.0001224397,0.0002315433,0.001944253,0.003183219,0.009329931,0.9087381],"study_design_scores_gemma":[0.00008608117,0.0005605543,0.003436291,0.06776533,0.00192768,0.003419401,0.0003743806,0.0001631746,0.003008332,0.003214069,0.915987,0.00005767621],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001978039,0.9986876,0.00005828659,0.0003906549,0.00009129708,0.000003539948,0.00001376673,0.000001773689,0.0005552699],"genre_scores_gemma":[0.002080082,0.9972911,0.0001346319,0.0002597239,0.00007164451,0.0000047856,0.00001982919,9.90287e-7,0.0001372099],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002816939,"threshold_uncertainty_score":0.01345092,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3128732576127962,"score_gpt":0.5311404830159735,"score_spread":0.2182672254031773,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}